SciELO - Scientific Electronic Library Online

 
vol.83 issue5Use of triamcinolone and bevacizumab in 25G phaco-vitrectomy surgery for the treatment of cataract and diabetic macular edemaThe relationships between ocular optical components and implications in the process of emmetropization author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Archivos de la Sociedad Española de Oftalmología

Print version ISSN 0365-6691

Abstract

BLANCO-RIVERA, C.; CAPEANS-TOME, C.  and  OTERO-CEPEDA, X.L.. Quality of life in patients with choroidal melanoma. Arch Soc Esp Oftalmol [online]. 2008, vol.83, n.5, pp.301-306. ISSN 0365-6691.

Purpose: To determine whether iodine 125 brachytherapy or enucleation is better for quality of life in patients treated for choroidal melanoma. Patients and methods: Sixty-five patients with choroidal melanoma were treated with a modified version of VF-14 iodine 125 brachytherapy, enucleation or both. Results of this treatment were then statistically analyzed. Results: Statistically significant differences were found between visual acuity in the affected eye and binocular vision (initial and final), with an important decline after the treatment. The global medial score in the VF questionnaire decreased in a statistically significant manner after the treatment. Conclusion: We can confirm that patients treated with brachytherapy had better health-related quality of life than those who had their eye enucleated and were more likely to have higher (better) scores on the VF questionnaire items. On the other hand, the binocular vision and time after the treatment correlated with the quality of life in long-term follow-up.

Keywords : Quality of life; choroidal melanoma; brachytherapy; enucleation; VF-14.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License